Trademark Overview
On Wednesday, March 12, 2025, a trademark application was filed for VELOCIVAX with the United States Patent and Trademark Office. The USPTO has given the VELOCIVAX trademark a serial number of 99080151. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Friday, July 18, 2025. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The VELOCIVAX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Pharmaceutical research services, namely, nucleic acid molecule development and nucleic acid molecule delivery development and production; genetic engineering services utilizing a collection of genetic technologies for the production and delivery of immune modulators; scientific, laboratory and medical research in the field of genetic engineering technologies; scientific laboratories performing nucleic acid molecule development and nucleic acid molecule delivery development; scientific research and development, namely, development of nucleic acid molecule and nucleic acid molecule delivery for others